As I had earlier reported, in at least one of the putative class actions, Dechert LLP is representing Schering, Merck and the Joint Venture defendants — last night, in a letter, it became clear[er] that the firm is gearing-up for a longer fight. . . . Take a look — click to enlarge:
To be clear, I think the various plantiffs’ lawyers on the almost-finalized litigation steering committee roster will be found more than adequately-expert to zealously prosecute, and protect the tens of thousands of individual plaintiffs’ interests, here. That is, this Dechert letter (and ultimately, the to-be-filed related motion) will go um. . . nowhere.